283 related articles for article (PubMed ID: 33842535)
1. Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma.
Liu W; Jiang K; Wang J; Mei T; Zhao M; Huang D
Front Mol Biosci; 2021; 8():605754. PubMed ID: 33842535
[TBL] [Abstract][Full Text] [Related]
2. Independent Prognostic Potential of GNPNAT1 in Lung Adenocarcinoma.
Zheng X; Li Y; Ma C; Zhang J; Zhang Y; Fu Z; Luo H
Biomed Res Int; 2020; 2020():8851437. PubMed ID: 33178836
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of glucosamine-phosphate N-acetyltransferase 1 is a promising diagnostic and predictive indicator for poor survival in patients with lung adenocarcinoma.
Zhu P; Gu S; Huang H; Zhong C; Liu Z; Zhang X; Wang W; Xie S; Wu K; Lu T; Zhou Y
Oncol Lett; 2021 Jun; 21(6):488. PubMed ID: 33968204
[TBL] [Abstract][Full Text] [Related]
4. GNPNAT1 is a potential biomarker correlated with immune infiltration and immunotherapy outcome in breast cancer.
Yuan R; Zhang Y; Wang Y; Chen H; Zhang R; Hu Z; Chai C; Chen T
Front Immunol; 2023; 14():1152678. PubMed ID: 37215111
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
6. Potential role of glucosamine-phosphate N-acetyltransferase 1 in the development of lung adenocarcinoma.
Zhang S; Zhang H; Li H; Guo J; Wang J; Zhang L
Aging (Albany NY); 2021 Mar; 13(5):7430-7453. PubMed ID: 33686019
[TBL] [Abstract][Full Text] [Related]
7. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
[TBL] [Abstract][Full Text] [Related]
8. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
Ma C; Kang W; Yu L; Yang Z; Ding T
Front Oncol; 2020; 10():590006. PubMed ID: 33363020
[TBL] [Abstract][Full Text] [Related]
9. Cancer/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
Jiang Y; Yu L; Hu Q; Kang Y; You J; Huang C; Xu X; Chen L
Mol Immunol; 2023 Jan; 153():226-237. PubMed ID: 36563642
[TBL] [Abstract][Full Text] [Related]
10. HMMR associates with immune infiltrates and acts as a prognostic biomaker in lung adenocarcinoma.
Ma X; Xie M; Xue Z; Yao J; Wang Y; Xue X; Wang J
Comput Biol Med; 2022 Dec; 151(Pt A):106213. PubMed ID: 36306573
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of SLC35F2 is a potential prognostic biomarker for lung adenocarcinoma.
Zheng Q; Li M; Qiu Y; Yang J; Cao Y
Heliyon; 2024 Jan; 10(1):e23828. PubMed ID: 38187235
[TBL] [Abstract][Full Text] [Related]
12. Pan-cancer analysis identifies
Yang H; Wei X; Zhang L; Xiang L; Wang P
Transl Cancer Res; 2022 Aug; 11(8):2902-2916. PubMed ID: 36093552
[TBL] [Abstract][Full Text] [Related]
13. Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma.
Yuan Y; Xie B; Guo D; Liu C; Jiang G; Lai G; Zhang Y; Hu X; Wu Z; Zheng R; Huang L
Heliyon; 2023 Jul; 9(7):e18065. PubMed ID: 37539167
[TBL] [Abstract][Full Text] [Related]
14. GNPNAT1 Predicts Poor Prognosis and Cancer Development in Non-Small Cell Lung Cancer.
Feng Y; Li N; Ren Y
Cancer Manag Res; 2022; 14():2419-2428. PubMed ID: 35975106
[TBL] [Abstract][Full Text] [Related]
15. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma.
Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH
World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904
[TBL] [Abstract][Full Text] [Related]
16. Integrated analyzes identify CCT3 as a modulator to shape immunosuppressive tumor microenvironment in lung adenocarcinoma.
Huang J; Hu B; Yang Y; Liu H; Fan X; Zhou J; Chen L
BMC Cancer; 2023 Mar; 23(1):241. PubMed ID: 36918801
[TBL] [Abstract][Full Text] [Related]
17. Expression, Clinical Significance, Immune Infiltration, and Regulation Network of miR-3940-5p in Lung Adenocarcinoma Based on Bioinformatic Analysis and Experimental Validation.
Lin Z; Huang W; Xie Z; Yi Y; Li Z
Int J Gen Med; 2022; 15():6451-6464. PubMed ID: 35966511
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic analysis of Rho GTPase-activating protein 11A in lung adenocarcinoma.
Chen S; Duan H; Xie Y; Li X; Zhao Y
Ann Transl Med; 2021 May; 9(10):872. PubMed ID: 34164506
[TBL] [Abstract][Full Text] [Related]
19. Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma.
Bian T; Zheng M; Jiang D; Liu J; Sun H; Li X; Liu L; Zhang J; Liu Y
Cancer Cell Int; 2021 Mar; 21(1):144. PubMed ID: 33653340
[TBL] [Abstract][Full Text] [Related]
20.
Zheng X; Han L; Guan J; Chen C; Zhang Y; Zhang J; Zhang Y; Liu S; Su J; Liu M; Huang H
Front Oncol; 2023; 13():1274439. PubMed ID: 38152367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]